Trial intelligence / Profile preview

Randomized phase II trial of pediatric HIV NRTI combinations with nelfinavir or placebo

ISRCTN31541725Phase 2Completed

Sponsor
Medical Research Council
Start
Jan 1998
Modality
Small Molecules
01

Overview

Phase 2, randomised trial of lamivudine, zidovudine, abacavir and nelfinavir in Human immunodeficiency virus infection type 1 and acquired immunodeficiency syndrome (AIDS) (6 arms), sponsored by Medical Research Council. Started Jan 1998; status: completed.

02

Drugs

lamivudinezidovudineabacavirnelfinavir
03

Conditions

Human immunodeficiency virus infection type 1acquired immunodeficiency syndrome (AIDS)

Beyond the preview

Go deeper on ISRCTN31541725.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN31541725.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call